Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

G-Protein Coupled Receptors (GPCRs)

Published by Global Industry Analysts, Inc. Product code 912741
Published Content info 359 Pages
Delivery time: 1-2 business days
Price
Back to Top
G-Protein Coupled Receptors (GPCRs)
Published: October 1, 2020 Content info: 359 Pages
Description

A Lesson Taught by the Pandemic is the Need to Have Better Health Systems & More Effective Drugs. GPCRs to Reach $3.8 Billion On the Back of Increased Drug R&D Spending

The global market for G-Protein Coupled Receptors (GPCRs) is projected to reach US$3.8 billion by the year 2027, trailing a post COVID-19 CAGR of 5.7% over the analysis period 2020 through 2027. Global healthcare systems continue to be inadequate, leaving a lot to be desired. Over 50% of the world's population lacks access to essential health services. Low quality healthcare is increasing the burden of disease, morality in addition to pushing up medical costs. COVID-19 is bringing transformational change in the way the world is beginning to prioritize healthcare and drug development. Post pandemic, there will be robust need and demand for the development of new and affordable medicines. The scenario brings good news for G-Protein Coupled Receptors (GPCRs), given the fact that over 45% of all drugs work by targeting GPCRs. The most intensively studied class of drug targets, GPCRs represent signal-transducing molecules that transmit signals to cells. They play a key role in converting extracellular stimulus into intracellular responses, and are therefore responsible for all physiological processes. Also referred to as heptahelical receptor or seven-trans membrane receptor, GPCRs consist of a large family of trans-membrane receptor proteins that play a vital role in signal transduction pathways in various physiological processes. Thus, by targeting GPCRs, a number of cellular functions can be controlled. GPCR-based drugs represent around 40% of the total approved drugs available in the market.

In addition, GPCRs that were previously untargeted are fast becoming validated targets, with an average of 3.5 receptors each year. G protein-coupled receptors (GPCRs) are membrane proteins that are located on the surface of a cell. Human genome comprises of around 30,000 genes, of which around 10% (3,000) genes are found to be drug gable targets. Out of the 3,000 genes, GPCRs are encoded by approximately 800-1,000 genes in the human body, and thus, comprise of the largest cell-surface receptor family. Furthermore, in the GPCR superfamily only around 360 receptors are non-chemosensory/ non-sensory and thus, are identified as validated drug targets, while the remaining are sensory receptors. GPCRs are present only in eukaryotes such as choanoflagellates and yeast, as well as in animals. GPCRs are also called 7TM receptors, 7trans-membrane domain receptors, serpentine receptors, and G-protein linked receptors (GPLR), and heptahelical receptors. The transmembrane domains are linked by 3 extracellular and 3 intracellular loops. The most important feature of GPCRs is that they are expressed at the surface of the cell, and communicate certain specific aspects of the extra-cellular environment to the intra-cellular environment.

Drugs targeting GPCR have superior therapeutic benefits, as they are more active at cell surface receptors. The importance of GPCRs can be put into perspective by the fact that approximately 35% to 40% of all pharmaceutical drugs in the marketplace target G-protein coupled receptors, making it one of the most vital classes of proteins in the genome. G protein?coupled receptors (GPCRs) are important drug targets with about 35% of FDA approved drugs targeting these receptors. GPCRs stimulate cellular responses and signal transduction inside the cell, upon sensing molecules outside. GPCR respond to various agonists, including proteins, neurotransmitters, hormones, amines, and photon. Some of the agonists attach themselves to receptor's extra cellular loop, while others penetrate in the trans-membrane region. Upon activation, a conformational change is induced in the receptor, which in turn activates GPCRs and subsequently biochemical signals are transmitted in the cell. Over the past two decades, there has been much research on understanding working of the receptors at the molecular level. There are also many studies ongoing for developing structure based GPCR drug designing, based on discoveries that various ligands are able to bind to same receptor but stimulate association of other effector proteins to varying extents. Such concept of biased agonism as well as functional selectivity have opened up major possibilities for development of more effective drugs with more desired therapeutic impacts, all while preventing harmful side-effects. Already, there have been many illustrations of how such biased GPCR ligands could prove to be useful in treating various diseases. Nonetheless, there is still much to be learnt about the various mechanisms that govern functional selectivity and ligand bias. Growth is forecast to be primarily driven by the increasing interest in GPCR drug targets, superior understanding of GPCR membrane structures, identification, and crystallization of newer structures, development of more powerful and efficient GPCR screening tools and technologies, and successful extrapolation of known structural information to other GPCRs of therapeutic interest. More than 360 endoGPCRs represent the largest and most therapeutically targeted class of membrane receptors in humans. However only 30-40% that have well-defined biological ligands are drug gable at present. The remaining 60-70% hold significant potential for development of new drug therapeutics.

Competitors identified in this market include, among others,

  • Abcam PLC
  • BD Biosciences
  • Cisbio Bioassays
  • DiscoveRx Corporation
  • Enzo Life Sciences, Inc.
  • HD Biosciences (China) Co., Ltd.
  • MilliporeSigma
  • MilliporeSigma
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Thermo Fisher Scientific, Inc.
Table of Contents
Product Code: MCP-6269

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • GPCR: An Introduction
    • Important Role of GPCRs in Drug Discovery
    • Popular Types of GPCRs of Therapeutic Interest
    • Classification of GPCRs
    • Orphan GPCRs: A Promising Area for Drug Discovery
    • GPCR Signaling Pathways
    • Physiological Roles Performed by GPCRs
    • Outlook
    • Geographic Market Analysis
    • Challenges
    • Competition
    • Recent Market Activity
    • World Brands
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Therapeutic Potential of GPCRs Gains Wide Recognition
    • Allosteric Modulators and Implication of Allostery in Drug Discovery
    • GPCRs Registered as Targets for Approved Drugs with EMBL-CHEMBL, IUPHAR, and The DrugBank
    • GPCRs Registered as Targets for Approved Drugs with EMBL-CHEMBL
    • GPCRs Registered as Targets for Approved Drugs with International Union of Basic and Clinical Pharmacology (IUPHAR)
    • GPCRs Registered as Targets for Approved Drugs with The DrugBank
    • FDA Approved GPCR Targeting Drugs (Excl. Diagnostic Agents) for the Period 2015-2019
    • Hurdles Faced…
    • Developments in Structural Biology and Receptor Pharmacology Offer Novel Opportunities to GPCR Drug Discovery
    • In Silico Approaches Underway for GPCR Drug Screening
    • Microfluidic Cell Technology Holds Potential
    • Pipeline GPCR Drug Candidates Widen Prospects
    • Select GPCR Small Molecule Drugs in Active Clinical Development
    • GPCR Ligands (Agonist) in Phase III Clinical Development
    • GPCR Ligands (Antagonist) in Phase III Clinical Development
    • ION CHANNELS and GPCRs
    • New Indications to Aid Growth
    • CRISPR Holds Potential to Speed Up GPCR-based Drug Discovery
    • GPCR-targeted Drugs and Role in Cancer Treatment
    • Select FDA Approved Drugs and Antibodies against Various Cancer Types
    • Potential GPCR targets for Cancer Treatment
    • Anti GPCRs Drugs and Antibodies by Clinical Trial Phase
    • Rising Incidence of Cancer to Drive Drives Opportunities
    • EXHIBIT 1: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • EXHIBIT 2: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
    • GPCRs Evolve as Important Targets for Developing Novel Therapeutics for Neurodegerative Disorders
    • EXHIBIT 3: Number of Individuals Suffering from Alzheimer's in the US: 2020 and 2025
    • EXHIBIT 4: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • GPCRs: An Important Target for Cardiovascular Drugs
    • EXHIBIT 5: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • GPCR Screening and Targeting Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 2: World Historic Review for G-Protein Coupled Receptors (GPCRs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 3: World 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 5: World Historic Review for Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 6: World 12-Year Perspective for Cell Lines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Detection Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 8: World Historic Review for Detection Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 9: World 12-Year Perspective for Detection Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Cell Culture Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 11: World Historic Review for Cell Culture Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 12: World 12-Year Perspective for Cell Culture Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Ligands by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 14: World Historic Review for Ligands by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 15: World 12-Year Perspective for Ligands by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for cAMP Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 17: World Historic Review for cAMP Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 18: World 12-Year Perspective for cAMP Functional Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Calcium Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 20: World Historic Review for Calcium Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 21: World 12-Year Perspective for Calcium Functional Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for B-Arrestin Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 23: World Historic Review for B-Arrestin Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 24: World 12-Year Perspective for B-Arrestin Functional Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Radioligand Binding & GTPyS Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 26: World Historic Review for Radioligand Binding & GTPyS Functional Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 27: World 12-Year Perspective for Radioligand Binding & GTPyS Functional Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Internalization Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 29: World Historic Review for Internalization Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 30: World 12-Year Perspective for Internalization Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Other Assay Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 32: World Historic Review for Other Assay Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 33: World 12-Year Perspective for Other Assay Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 34: World Current & Future Analysis for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 35: World Historic Review for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 36: World 12-Year Perspective for Cancer Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 37: World Current & Future Analysis for Metabolic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 38: World Historic Review for Metabolic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 39: World 12-Year Perspective for Metabolic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 40: World Current & Future Analysis for Inflammation Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 41: World Historic Review for Inflammation Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 42: World 12-Year Perspective for Inflammation Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 43: World Current & Future Analysis for CNS Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 44: World Historic Review for CNS Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 45: World 12-Year Perspective for CNS Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 46: World Current & Future Analysis for Respiratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 47: World Historic Review for Respiratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 48: World 12-Year Perspective for Respiratory Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 49: World Current & Future Analysis for Cardiovascular Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 50: World Historic Review for Cardiovascular Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 51: World 12-Year Perspective for Cardiovascular Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027
    • TABLE 52: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 53: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 54: World 12-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • TABLE 55: USA Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 56: USA Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 57: USA 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Sales for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2020 & 2027
    • TABLE 58: USA Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 59: USA Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 60: USA 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Sales for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2020 & 2027
    • TABLE 61: USA Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 62: USA Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 63: USA 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Sales for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2020 & 2027
  • CANADA
    • TABLE 64: Canada Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 65: Canada Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 66: Canada 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Sales for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2020 & 2027
    • TABLE 67: Canada Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 68: Canada Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 69: Canada 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Sales for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2020 & 2027
    • TABLE 70: Canada Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 71: Canada Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 72: Canada 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Sales for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2020 & 2027
  • JAPAN
    • TABLE 73: Japan Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 74: Japan Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 75: Japan 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Sales for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2020 & 2027
    • TABLE 76: Japan Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 77: Japan Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 78: Japan 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Sales for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2020 & 2027
    • TABLE 79: Japan Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 80: Japan Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 81: Japan 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Sales for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2020 & 2027
  • CHINA
    • TABLE 82: China Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 83: China Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 84: China 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Sales for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2020 & 2027
    • TABLE 85: China Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 86: China Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 87: China 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Sales for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2020 & 2027
    • TABLE 88: China Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 89: China Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 90: China 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Sales for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2020 & 2027
  • EUROPE
    • TABLE 91: Europe Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 92: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 93: Europe 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2020 & 2027
    • TABLE 94: Europe Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 95: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 96: Europe 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Sales for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2020 & 2027
    • TABLE 97: Europe Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 98: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 99: Europe 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Sales for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2020 & 2027
    • TABLE 100: Europe Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 101: Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 102: Europe 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Sales for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2020 & 2027
  • FRANCE
    • TABLE 103: France Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 104: France Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 105: France 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Sales for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2020 & 2027
    • TABLE 106: France Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 107: France Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 108: France 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Sales for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2020 & 2027
    • TABLE 109: France Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 110: France Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 111: France 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Sales for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2020 & 2027
  • GERMANY
    • TABLE 112: Germany Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 113: Germany Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 114: Germany 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Sales for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2020 & 2027
    • TABLE 115: Germany Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 116: Germany Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 117: Germany 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Sales for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2020 & 2027
    • TABLE 118: Germany Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 119: Germany Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 120: Germany 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Sales for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2020 & 2027
  • ITALY
    • TABLE 121: Italy Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 122: Italy Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 123: Italy 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Sales for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2020 & 2027
    • TABLE 124: Italy Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 125: Italy Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 126: Italy 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Sales for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2020 & 2027
    • TABLE 127: Italy Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 128: Italy Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 129: Italy 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Sales for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 130: UK Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 131: UK Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 132: UK 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Sales for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2020 & 2027
    • TABLE 133: UK Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 134: UK Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 135: UK 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Sales for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2020 & 2027
    • TABLE 136: UK Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 137: UK Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 138: UK 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Sales for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2020 & 2027
  • REST OF EUROPE
    • TABLE 139: Rest of Europe Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 140: Rest of Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 141: Rest of Europe 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Sales for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2020 & 2027
    • TABLE 142: Rest of Europe Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 143: Rest of Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 144: Rest of Europe 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Sales for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2020 & 2027
    • TABLE 145: Rest of Europe Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 146: Rest of Europe Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 147: Rest of Europe 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Sales for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 148: Asia-Pacific Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 149: Asia-Pacific Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 150: Asia-Pacific 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Sales for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2020 & 2027
    • TABLE 151: Asia-Pacific Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 152: Asia-Pacific Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 153: Asia-Pacific 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Sales for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2020 & 2027
    • TABLE 154: Asia-Pacific Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 155: Asia-Pacific Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 156: Asia-Pacific 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Sales for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2020 & 2027
  • REST OF WORLD
    • TABLE 157: Rest of World Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 158: Rest of World Historic Review for G-Protein Coupled Receptors (GPCRs) by Product - Cell Lines, Detection Kits, Cell Culture Reagents and Ligands Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 159: Rest of World 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Product - Percentage Breakdown of Value Sales for Cell Lines, Detection Kits, Cell Culture Reagents and Ligands for the Years 2015, 2020 & 2027
    • TABLE 160: Rest of World Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 161: Rest of World Historic Review for G-Protein Coupled Receptors (GPCRs) by Assay Type - cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 162: Rest of World 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Assay Type - Percentage Breakdown of Value Sales for cAMP Functional Assays, Calcium Functional Assays, B-Arrestin Functional Assays, Radioligand Binding & GTPyS Functional Assays, Internalization Assays and Other Assay Types for the Years 2015, 2020 & 2027
    • TABLE 163: Rest of World Current & Future Analysis for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 164: Rest of World Historic Review for G-Protein Coupled Receptors (GPCRs) by Application - Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2019
    • TABLE 165: Rest of World 12-Year Perspective for G-Protein Coupled Receptors (GPCRs) by Application - Percentage Breakdown of Value Sales for Cancer Research, Metabolic Research, Inflammation Research, CNS Research, Respiratory Research, Cardiovascular Research and Other Applications for the Years 2015, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 52
Back to Top